// App-Quantinova.ai

BSH19‐EP‐086 : When is chronic myeloid leukaemia ‘cured’? Relapse post allogeneic bone marrow transplantation after 32 years

Researchers

Presenter

  • M. Bolaji

Principal Investigators

  • K. Knight

  • A. Patel

Medical Centers

  • Stem Cell Transplantation and Cellular Therapy Unit, The Clatterbridge Cancer Centre NHS Foundation Trust

  • University of Liverpool, Liverpool, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Oncology (ONC)

Disease

  • Chronic Myelogenous Leukemia

  • Graft-versus-host disease

Biomarkers

  • Abelson murine leukemia viral oncogene homolog

  • Breakpoint Cluster Region

  • Soluble Complement 5b-9

  • White Blood Cell

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Tabloid

  • cyclosporin

  • Imatinib

  • IkT001

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved